Overview of the methods and therapies for the primary prevention of variceal bleeding

References

• D’Amico G, Luca A. Natural history. Clinical–haemodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin. Gastroenterol.11(2), 243–256 (1997).
   PubMed Web of Science ®Google Scholar
• Stokkeland K, Brandt L, Ekbom A, Hultcrantz R. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969–2002. Hepatology43(3), 500–505 (2006).
   PubMed Web of Science ®Google Scholar
• D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology22(1), 332–354 (1995).
   PubMed Web of Science ®Google Scholar
• Hayes PC, Davis JM, Lewis JA, Bouchier IA. Meta-analysis of value of propranolol in prevention of variceal hemorrhage. Lancet336(8708), 153–156 (1990).
   PubMed Web of Science ®Google Scholar
• Poynard T, Cales P, Pasta L et al. β-adrenergic antagonist drugs in the prevention of gastrointestinal-bleeding in patients with cirrhosis and esophageal-varices – an analysis of data and prognostic factors in 589 patients from four randomized clinical trials. N. Engl. J. Med.324(22), 1532–1538 (1991).
   PubMed Web of Science ®Google Scholar
• Cheng JW, Zhu L, Gu MJ, Song ZM. Meta analysis of propranolol effects on gastrointestinal hemorrhage in cirrhotic patients. World J. Gastroenterol.9(8), 1836–1839 (2003).
   PubMed Web of Science ®Google Scholar
• Tripathi D, Ferguson JW, Kochar N et al. Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology50(3), 825–833 (2009).
   PubMed Web of Science ®Google Scholar
• de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J. Hepatol.43(1), 167–176 (2005).
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology46(3), 922–938 (2007).
   PubMed Web of Science ®Google Scholar
• Triantos C, Vlachogiannakos J, Manolakopoulos S, Burroughs A, Avgerinos A. Is banding ligation for primary prevention of variceal bleeding as effective as β-blockers, and is it safe? Hepatology43(1), 196–197 (2006).
   PubMed Web of Science ®Google Scholar
• Ferguson JW, Tripathi D, Hayes PC. Endoscopic diagnosis, grading and predictors of bleeding in esophageal and gastric varices. Tech. Gastrointest. Endosc.7, 2–7 (2005).
   Google Scholar
• North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N. Engl. J. Med.319(15), 983–989 (1988).
   PubMed Web of Science ®Google Scholar
• Agha A, Anwar E, Bashir K, Savarino V, Giannini EG. External validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosis. Dig. Dis. Sci.54(3), 654–660 (2009).
   PubMed Web of Science ®Google Scholar
• Giannini EG, Zaman A, Kreil A et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am. J. Gastroenterol.101(11), 2511–2519 (2006).
   PubMed Web of Science ®Google Scholar
• de Franchis R, Eisen GM, Laine L et al. Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. Hepatology47(5), 1595–1603 (2008).
   PubMed Web of Science ®Google Scholar
• Vizzutti F, Arena U, Romanelli RG et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology45(5), 1290–1297 (2007).
   PubMed Web of Science ®Google Scholar
• Kazemi F, Kettaneh A, N’kontchou G et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J. Hepatol.45(2), 230–235 (2006).
   PubMed Web of Science ®Google Scholar
• Castera L, Le Bail B, Roudot-Thoraval F et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J. Hepatol.50(1), 59–68 (2009).
   PubMed Web of Science ®Google Scholar
• Lebrec D, Hillon P, Munoz C, Goldfarb G, Nouel O, Benhamou JP. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology2(5), 523–527 (1982).
   PubMed Web of Science ®Google Scholar
• Bosch J, Masti R, Kravetz D et al. Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology4(6), 1200–1205 (1984).
   PubMed Web of Science ®Google Scholar
• Mastai R, Bosch J, Navasa M et al. Effects of α-adrenergic stimulation and β-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis. J. Hepatol.4(1), 71–79 (1987).
   PubMed Web of Science ®Google Scholar
• Boyer TD, Triger DR, Horisawa M, Redeker AG, Reynolds TB. Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic vein pressure. Gastroenterology72(4 Pt 1), 584–589 (1977).
   PubMed Web of Science ®Google Scholar
• Lin HC, Tsai YT, Lee FY, Chang TT et al. Comparison between portal vein pressure and wedged hepatic vein pressure in hepatitis B-related cirrhosis. J. Hepatol.9(3), 326–330 (1989).
   PubMed Web of Science ®Google Scholar
• Perello A, Escorsell A, Bru C et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology30(6), 1393–1397 (1999).
   PubMed Web of Science ®Google Scholar
• Kroeger RJ, Groszmann RJ. Increased portal venous resistance hinders portal pressure reduction during the administration of β-adrenergic blocking agents in a portal hypertensive model. Hepatology5(1), 97–101 (1985).
   PubMed Web of Science ®Google Scholar
• Vorobioff J, Picabea E, Villavicencio R et al. Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients. Hepatology7(4), 648–653 (1987).
   PubMed Web of Science ®Google Scholar
• Groszmann RJ, Bosch J, Grace ND et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology99(5), 1401–1407 (1990).
   PubMed Web of Science ®Google Scholar
• Feu F, Garcia-Pagan JC, Bosch J et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet346(8982), 1056–1059 (1995).
   PubMed Web of Science ®Google Scholar
• Garcia-Pagan JC. Isosorbide-5-monitrate (ISMN) vs placebo (PLA) in the prevention of the first variceal bleeding (FVB) in patients with contraindications or intolerance to β-blockers. J. Hepatol.32, 28 (2000).
   Google Scholar
• Angelico M, Carli L, Piat C, Gentile S, Capocaccia L. Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis. Gastroenterology113(5), 1632–1639 (1997).
   PubMed Web of Science ®Google Scholar
• Borroni G, Salerno F, Cazzaniga M et al. Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites. J. Hepatol.37(3), 315–321 (2002).
   PubMed Web of Science ®Google Scholar
• Merkel C, Marin R, Sacerdoti D et al. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Hepatology31(2), 324–329 (2000).
   PubMed Web of Science ®Google Scholar
• Garcia-Pagan JC, Morillas R, Banares R et al. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT. Hepatology37(6), 1260–1266 (2003).
   PubMed Web of Science ®Google Scholar
• Gluud LL, Langholz E, Krag A. Isosorbide mononitrate for patients with esophageal varices: systematic review of randomized trials on primary or secondary prevention. Hepatology50(4), 285 (2009).
   Google Scholar
• Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial. The Veterans Affairs Cooperative Variceal Sclerotherapy Group. N. Engl. J. Med.324(25), 1779–1784 (1991).
   PubMed Web of Science ®Google Scholar
• Avgerinos A, Armonis A, Manolakopoulos S et al. Endoscopic sclerotherapy plus propranolol versus propranolol alone in the primary prevention of bleeding in high risk cirrhotic patients with esophageal varices: a prospective multicenter randomized trial. Gastrointest. Endosc.51(6), 652–658 (2000).
   PubMed Web of Science ®Google Scholar
• Gotoh Y, Iwakiri R, Sakata Y et al. Evaluation of endoscopic variceal ligation in prophylactic therapy for bleeding of oesophageal varices: a prospective, controlled trial compared with endoscopic injection sclerotherapy. J. Gastroenterol. Hepatol.14(3), 241–244 (1999).
   PubMed Web of Science ®Google Scholar
• Masumoto H, Toyonaga A, Oho K, Iwao T, Tanikawa K. Ligation plus low-volume sclerotherapy for high-risk esophageal varices: comparisons with ligation therapy or sclerotherapy alone. J. Gastroenterol.33(1), 1–5 (1998).
   PubMedGoogle Scholar
• Van Stiegmann G. Endoscopic ligation of esophageal varices. Am. J. Surg.156(3 Pt 2), 9B–12B (1988).
   Google Scholar
• Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology33(4), 802–807 (2001).
   PubMed Web of Science ®Google Scholar
• De BK, Ghoshal UC, Das T, Santra A, Biswas PK. Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trial. J. Gastroenterol. Hepatol.14(3), 220–224 (1999).
   PubMed Web of Science ®Google Scholar
• Jutabha R, Jensen DM, Martin P, Savides T, Han SH, Gornbein J. Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices. Gastroenterology128(4), 870–881 (2005).
   PubMed Web of Science ®Google Scholar
• Lay CS, Tsai YT, Lee FY et al. Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis. J. Gastroenterol. Hepatol.21(2), 413–419 (2006).
   PubMed Web of Science ®Google Scholar
• Lo GH, Chen WC, Chen MH et al. Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest. Endosc.59(3), 333–338 (2004).
   PubMed Web of Science ®Google Scholar
• Lui HF, Stanley AJ, Forrest EH et al. Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology123(3), 735–744 (2002).
   PubMed Web of Science ®Google Scholar
• Norberto L, Polese L, Cillo U et al. A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. Liver Transpl.13(9), 1272–1278 (2007).
   PubMed Web of Science ®Google Scholar
• Psilopoulos D, Galanis P, Goulas S et al. Endoscopic variceal ligation vs. propranolol for prevention of first variceal bleeding: a randomized controlled trial. Eur. J. Gastroenterol. Hepatol.17(10), 1111–1117 (2005).
   PubMed Web of Science ®Google Scholar
• Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N. Engl. J. Med.340(13), 988–993 (1999).
   PubMed Web of Science ®Google Scholar
• Schepke M, Kleber G, Nurnberg D et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology40(1), 65–72 (2004).
   PubMed Web of Science ®Google Scholar
• Thuluvath PJ, Maheshwari A, Jagannath S, Arepally A. A randomized controlled trial of β-blockers versus endoscopic band ligation for primary prophylaxis: a large sample size is required to show a difference in bleeding rates. Dig. Dis. Sci.50(2), 407–410 (2005).
   PubMed Web of Science ®Google Scholar
• Tripathi D, Hayes PC. The role of carvedilol in the management of portal hypertension. Eur. J. Gastroenterol. Hepatol. DOI: 10.1097/MEG.0b013e3283367a99 (2010) (Epub ahead of print).
   Google Scholar
• Garcia-Tsao G, Grace ND, Groszmann RJ et al. Short-term effects of propranolol on portal venous pressure. Hepatology6(1), 101–106 (1986).
   Google Scholar
• Tripathi D, Graham C, Hayes PC. Variceal band ligation versus β-blockers for primary prevention of variceal bleeding: a meta-analysis. Eur. J. Gastroenterol. Hepatol.19(10), 835–845 (2007).
   PubMed Web of Science ®Google Scholar
• Gluud LL, Klingenberg S, Nikolova D, Gluud C. Banding ligation versus β-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials. Am. J. Gastroenterol.102(12), 2842–2848 (2007).
   PubMed Web of Science ®Google Scholar
• Lo GH, Chen WC, Chen MH et al. Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology123(3), 728–734 (2002).
   PubMed Web of Science ®Google Scholar
• Sarin SK, Wadhawan M, Agarwal SR, Tyagi P, Sharma BC. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am. J. Gastroenterol.100(4), 797–804 (2005).
   PubMed Web of Science ®Google Scholar
• Gheorghe C, Gheorghe L, Iacob S, Iacob R, Popescu I. Primary prophylaxis of variceal bleeding in cirrhotics awaiting liver transplantation. Hepatogastroenterology53(70), 552–557 (2006).
   PubMedGoogle Scholar
• Groszmann RJ, Garcia-Tsao G, Bosch J et al. β-blockers to prevent gastroesophageal varices in patients with cirrhosis. N. Engl. J. Med.353(21), 2254–2261 (2005).
   PubMed Web of Science ®Google Scholar
• Plevris JN, Elliot R, Mills PR et al. Effect of propranolol on prevention of first variceal bleed and survival in patients with chronic liver-disease. Aliment. Pharmacol. Ther.8(1), 63–70 (1994).
   PubMed Web of Science ®Google Scholar
• Strauss E, Ribeiro MF, Albano A, Honain NZ, Maffei RA Jr, Caly WR. Long-term follow up of a randomized, controlled trial on prophylactic sclerotherapy of small oesophageal varices in liver cirrhosis. J. Gastroenterol. Hepatol.14(3), 225–230 (1999).
   PubMed Web of Science ®Google Scholar
• Triantos C, Vlachogiannakos J, Armonis A et al. Primary prophylaxis of variceal bleeding in cirrhotics unable to take β-blockers: a randomized trial of ligation. Aliment. Pharmacol. Ther.21(12), 1435–1443 (2005).
   PubMed Web of Science ®Google Scholar
• Cales P, Oberti F, Payen JL et al. Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. Eur. J. Gastroenterol. Hepatol.11(7), 741–745 (1999).
   PubMed Web of Science ®Google Scholar
• Merkel C, Marin R, Angeli P et al. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology127(2), 476–484 (2004).
   PubMed Web of Science ®Google Scholar
• Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology16(6), 1343–1349 (1992).
   PubMed Web of Science ®Google Scholar
• Arakaki Y, Murakami K, Takahashi K et al. Clinical evaluation of combined endoscopic variceal ligation and sclerotherapy of gastric varices in liver cirrhosis. Endoscopy35(11), 940–945 (2003).
   PubMed Web of Science ®Google Scholar
• Yoshida T, Harada T, Shigemitsu T, Takeo Y, Miyazaki S, Okita K. Endoscopic management of gastric varices using a detachable snare and simultaneous endoscopic sclerotherapy and O-ring ligation. J. Gastroenterol. Hepatol.14(7), 730–735 (1999).
   PubMed Web of Science ®Google Scholar
• Mishra SR, Sharma B, Kumar A, Sarin SK. Primary prophylaxis of gastric variceal bleed comparing cyanoacrylate injection and β-blockers. Hepatology50(4), 209 (2009).
   Google Scholar
• Joshi D, Wendon J, Auzinger G. Stroke after injection of gastric varices. Liver Int.29(3), 374 (2009).
   PubMed Web of Science ®Google Scholar
• Marion-Audibert AM, Schoeffler M, Wallet F et al. Acute fatal pulmonary embolism during cyanoacrylate injection in gastric varices. Gastroenterol. Clin. Biol.32(11), 926–930 (2008).
   PubMedGoogle Scholar